DBH used at a non-cytotoxic concentration (3 μM) in association with radiotherapy (2 or 5 Gy) was able to reduce Chk1/2 phosphorylation in human breast cancer cells (MCF7). The gene discussed is CHEK1; the disease is breast carcinoma.